1. Home
  2. INUV vs BOLD Comparison

INUV vs BOLD Comparison

Compare INUV & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$1.86

Market Cap

28.3M

ML Signal

HOLD

Logo Boundless Bio Inc.

BOLD

Boundless Bio Inc.

HOLD

Current Price

$1.56

Market Cap

25.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INUV
BOLD
Founded
N/A
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
28.3M
25.7M
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
INUV
BOLD
Price
$1.86
$1.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$11.00
$4.00
AVG Volume (30 Days)
217.9K
96.5K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
32.47
EPS
N/A
N/A
Revenue
$86,209,305.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.88
N/A
52 Week Low
$0.34
$0.96
52 Week High
$6.27
$1.78

Technical Indicators

Market Signals
Indicator
INUV
BOLD
Relative Strength Index (RSI) 39.01 79.51
Support Level $1.83 $1.12
Resistance Level $1.99 N/A
Average True Range (ATR) 0.16 0.07
MACD -0.02 0.03
Stochastic Oscillator 13.73 80.33

Price Performance

Historical Comparison
INUV
BOLD

About INUV Inuvo Inc.

Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About BOLD Boundless Bio Inc.

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: